Back to search

Article

Transthyretin-stabilizing mutation T119M is not associated with protection against vascular disease or death in the UK Biobank

2019-09-21

Abstract excerpt

<h4>Background</h4> Destabilized transthyretin (TTR) can result in the progressive, fatal disease transthyretin-mediated (ATTR) amyloidosis. A stabilizing TTR mutation, T119M, is the basis for a therapeutic strategy to reduce destabilized TTR. Recently, T119M was associated with extended lifespan and lower risk of cerebrovascular disease in a Danish cohort. We aimed to determine whether this finding could be rep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f9c377fa-ca69-5ba7-afbd-e8e3ae6fa235
DOI
10.1101/771626
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transthyretin-stabilizing mutation T119M is not associated with protection against vascular disease or death in the UK BiobankDOI 10.1101/771626
Select a neighboring publication to make it the new centre.